癌症治疗中的创新:内源性刺激响应性脂质体作为先进的纳米载体
Jazmín Torres1,2, Johanna Karina Valenzuela Oses1,2, Antonio María Rabasco-Álvarez3
1Departamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Haya de la Torre and Medina Allende, Ciudad Universitaria, Science Building 2, Córdoba X5000HUA, Argentina.
Pharmaceutics
|February 26, 2025
概括
智能脂质体 (L) 通过响应内部和外部触发器来提供先进的癌症治疗,以精确的药物输送. 这些纳米载体提高了治疗效率,减少了副作用.
科学领域:
- 纳米技术纳米技术
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
背景情况:
- 脂质体 (L) 是生物相容的纳米纤维,用于药物输送.
- 响应刺激的L提供基于特定触发器的向药物释放.
- 双响应和多响应的L为癌症治疗提供了更高的精度.
研究的目的:
- 审查刺激响应性脂肪体纳米载体用于癌症治疗的最新进展.
- 专注于内源刺激响应的L,以及双重和多重响应的L.
- 讨论这些智能L的设计策略,机制和应用.
主要方法:
- 在癌症治疗中纳米技术进步的文献综述.
- 对刺激反应的脂质体纳米载体设计和机制的分析.
- 探索在向药物输送和受控释放中的应用.
主要成果:
- 响应刺激的L增强药物封装和释放.
- 双响应和多响应的L可以提高治疗精度,降低毒性.
- 智能L能够实现特定地点的向和可控的药物释放.
结论:
- 基于纳米技术的脂质体正在彻底改变癌症治疗.
- 刺激响应,双响应和多响应L在有效性和安全性方面提供了显著的优势.
- 对智能L设计和应用的进一步研究对瘤治疗有很大的前景.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
462
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
462
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


